Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Real-world Use and Effectiveness of Cytoreductive Strategies for the Treatment of Second-line Polycythemia Vera in France
Sponsor: Novartis Pharmaceuticals
Summary
The aim of this study was to assess which cytoreductive treatments are currently administered in standard practice as second-line therapy to patients with polycythemia vera (PV) in France and to find out the reasons physicians switch treatments. In addition, the research aimed to describe real-world effectiveness of second-line cytoreductive therapies and the occurrence of adverse events of special interest. Study data were collected from the medical charts of patients who initiated a second-line cytoreductive agent for the treatment of PV and received their first dose between 1 Jan 2022 and 31 Dec 2023.
Official title: Real-world Use and Effectiveness of Cytoreductive Strategies for the Treatment of Second-line Polycythemia Vera: A Multicenter, Retrospective, Non-interventional Study in France
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
237
Start Date
2025-03-13
Completion Date
2025-10-14
Last Updated
2026-09-24
Healthy Volunteers
No
Conditions
Locations (51)
Novartis Investigative Site
Bayonne, Bayonne Cedex, France
Novartis Investigative Site
Saint Priest Jarez, Pays de la Loire Region, France
Novartis Investigative Site
Aix-en-Provence, France
Novartis Investigative Site
Amiens, France
Novartis Investigative Site
Angers, France
Novartis Investigative Site
Antony, France
Novartis Investigative Site
Arras, France
Novartis Investigative Site
Aurillac, France
Novartis Investigative Site
Avignon, France
Novartis Investigative Site
Béziers, France
Novartis Investigative Site
Bordeaux, France
Novartis Investigative Site
Brest, France
Novartis Investigative Site
Cesson-Sévigné, France
Novartis Investigative Site
Challes-les-Eaux, France
Novartis Investigative Site
Chambéry, France
Novartis Investigative Site
Clermont-Ferrand, France
Novartis Investigative Site
Corbeil-Essonnes, France
Novartis Investigative Site
Dunkirk, France
Novartis Investigative Site
Essey-lès-Nancy, France
Novartis Investigative Site
Grenoble, France
Novartis Investigative Site
Le Bouscat, France
Novartis Investigative Site
Le Chesnay, France
Novartis Investigative Site
Le Coudray, France
Novartis Investigative Site
Le Kremlin-Bicêtre, France
Novartis Investigative Site
Le Mans, France
Novartis Investigative Site
Libourne, France
Novartis Investigative Site
Lille, France
Novartis Investigative Site
Lyon, France
Novartis Investigative Site
Marseille, France
Novartis Investigative Site
Montpellier, France
Novartis Investigative Site
Morlaix Cdex, France
Novartis Investigative Site
Nantes, France
Novartis Investigative Site
Nîmes, France
Novartis Investigative Site
Orléans, France
Novartis Investigative Site
Paris, France
Novartis Investigative Site
Paris, France
Novartis Investigative Site
Paris, France
Novartis Investigative Site
Paris, France
Novartis Investigative Site
Perpignan, France
Novartis Investigative Site
Pessac, France
Novartis Investigative Site
Pierre-Bénite, France
Novartis Investigative Site
Poitiers, France
Novartis Investigative Site
Quimper, France
Novartis Investigative Site
Rennescedex9, France
Novartis Investigative Site
Rochefort, France
Novartis Investigative Site
Roubaix, France
Novartis Investigative Site
Saint-Brieuc, France
Novartis Investigative Site
St-Malo, France
Novartis Investigative Site
Strasbourg, France
Novartis Investigative Site
Trévenans, France
Novartis Investigative Site
Troyes, France